EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of a biocompatible 3D hydrogel scaffold using continuous liquid interface production for the delivery of cell therapies to treat recurrent glioblastoma

Lauren Kass iD, Morrent Thang, Yu Zhang, Cathleen DeVane, Julia Logan, Addis Tessema, Jillian Perry, Shawn Hingtgen

Bioengineering & Translational Medicine · 2024-11 · 9 (6)

DOI: 10.1002/btm2.10676 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioengineering & Translational Medicine, online erschienen am 30.07.2024. Verfasst von Lauren Kass und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmacoengineering and Molecular Pharmaceutics, UNC Eshelman School of Pharmacy The University of North Carolina at Chapel Hill Chapel H…. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM) is the most common primary malignant brain tumor diagnosed in adults, carrying with it an extremely poor prognosis and limited options for effective treatment. Various cell therapies have emerged as promising candidates for GBM treatment but fail in the clinic due to poor tumor trafficking, poor transplantation efficiency, and high systemic toxicity. In this study, we design, characterize, and test a 3D‐printed cell delivery platform that can enhance the survival of therapeutic cells implanted in the GBM resection cavity. Using continuous liquid interface production (CLIP) to generate a biocompatible 3D hydrogel, we demonstrate that we can effectively seed neural stem cells (NSCs) onto the surface of the hydrogel, and that the cells can proliferate to high densities when cultured for 14 days in vitro . We show that NSCs seeded on CLIP scaffolds persist longer than freely injected cells in vivo, proliferating to 20% higher than their original density in 6 days after implantation. Finally, we demonstrate that therapeutic fibroblasts seeded on CLIP more effectively suppress tumor growth and extend survival in a mouse model of LN229 GBM resection compared to the scaffold or therapeutic cells alone. These promising results demonstrate the potential to leverage CLIP to design hydrogels with various features to control the delivery of different types of cell therapies. Future work will include a more thorough evaluation of the immunological response to the material and improvement of the printing resolution for biocompatible aqueous resins.

Schlagwörter

Stichwörter der Autor:innen

3D printingCLIPcell therapyglioblastomascaffold

Autor:innen und Institutionen

  • Division of Pharmacoengineering and Molecular Pharmaceutics, UNC Eshelman School of Pharmacy The University of North Carolina at Chapel Hill Chapel Hill North Carolina USA.
  • Department of Chemistry, UNC College of Arts and Sciences The University of North Carolina at Chapel Hill Chapel Hill North Carolina USA.
  • Center for Nanotechnology in Drug Delivery, Eshelman School of Pharmacy The University of North Carolina at Chapel Hill Chapel Hill North Carolina USA.
  • Lineberger Comprehensive Cancer Center The University of North Carolina at Chapel Hill Chapel Hill North Carolina USA.

ORCID-Profile: Lauren Kass

Förderung

  • NCI NIH HHS
  • NIH HHS
  • National Cancer Institute

Zitieren

APA

Kass, L., Thang, M., Zhang, Y., DeVane, C., Logan, J., Tessema, A., Perry, J., & Hingtgen, S. (2024). Development of a biocompatible 3D hydrogel scaffold using continuous liquid interface production for the delivery of cell therapies to treat recurrent glioblastoma. Bioengineering & Translational Medicine, 9(6). https://doi.org/10.1002/btm2.10676

Vancouver

Kass L, Thang M, Zhang Y, DeVane C, Logan J, Tessema A, et al. Development of a biocompatible 3D hydrogel scaffold using continuous liquid interface production for the delivery of cell therapies to treat recurrent glioblastoma. Bioengineering & Translational Medicine. 2024;9(6). doi:10.1002/btm2.10676

BibTeX
@article{Kass2024,
  author = {Kass, Lauren and Thang, Morrent and Zhang, Yu and DeVane, Cathleen and Logan, Julia and Tessema, Addis and Perry, Jillian and Hingtgen, Shawn},
  title = {Development of a biocompatible 3D hydrogel scaffold using continuous liquid interface production for the delivery of cell therapies to treat recurrent glioblastoma},
  journal = {Bioengineering & Translational Medicine},
  year = {2024},
  volume = {9},
  number = {6},
  doi = {10.1002/btm2.10676}
}
Kostenlos starten →